We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVX icon
1751
V2X
VVX
$2.83B
$2.32M ﹤0.01%
33,843
+3,610
+12% +$244K
TNK icon
1752
Teekay Tankers
TNK
$2.65B
$2.3M ﹤0.01%
31,433
+296
+1% +$19.8K
LGIH icon
1753
LGI Homes
LGIH
$1.46B
$2.3M ﹤0.01%
58,201
+1,283
+2% +$62.5K
QS icon
1754
QuantumScape Corp
QS
$3.15B
$2.29M ﹤0.01%
359,557
-6,998
-2% -$58.1K
DCO icon
1755
Ducommun
DCO
$2.67B
$2.28M ﹤0.01%
18,687
-274
-1% -$32.8K
ORKA
1756
Oruka Therapeutics
ORKA
$5.39B
$2.27M ﹤0.01%
46,356
+5,339
+13% +$186K
BWIN
1757
Baldwin Insurance Group
BWIN
$2.84B
$2.27M ﹤0.01%
103,492
+17,339
+20% +$375K
DFTX
1758
Definium Therapeutics
DFTX
$5.47B
$2.27M ﹤0.01%
119,972
+9,225
+8% +$157K
SPB icon
1759
Spectrum Brands
SPB
$2.06B
$2.27M ﹤0.01%
30,754
-2,389
-7% -$170K
TENB icon
1760
Tenable Holdings
TENB
$3.56B
$2.26M ﹤0.01%
133,886
-18,246
-12% -$383K
TAK icon
1761
Takeda Pharmaceutical
TAK
$56.2B
$2.25M ﹤0.01%
121,661
+4,025
+3% +$70.6K
NTST
1762
NETSTREIT Corp
NTST
$2.14B
$2.25M ﹤0.01%
119,651
-573
-0.5% -$11K
SMFG icon
1763
Sumitomo Mitsui Financial
SMFG
$163B
$2.25M ﹤0.01%
113,989
+5,567
+5% +$117K
BLBD icon
1764
Blue Bird Corp
BLBD
$2.27B
$2.25M ﹤0.01%
39,635
-47
-0.1% -$2.54K
DAVE icon
1765
Dave Inc
DAVE
$5B
$2.25M ﹤0.01%
12,911
+259
+2% +$50.3K
AMN icon
1766
AMN Healthcare
AMN
$1.33B
$2.24M ﹤0.01%
122,110
+3,187
+3% +$60.6K
KOP icon
1767
Koppers
KOP
$967M
$2.24M ﹤0.01%
57,867
+358
+0.6% +$12K
FTRE icon
1768
Fortrea Holdings
FTRE
$1.97B
$2.24M ﹤0.01%
237,468
+4,877
+2% +$62.7K
USLM icon
1769
United States Lime & Minerals
USLM
$3.37B
$2.24M ﹤0.01%
17,125
-2,142
-11% -$257K
AMPX icon
1770
Amprius Technologies
AMPX
$1.28B
$2.23M ﹤0.01%
132,093
+6,939
+6% +$90.5K
SMP icon
1771
Standard Motor Products
SMP
$899M
$2.22M ﹤0.01%
64,022
+3,686
+6% +$145K
PAC icon
1772
Grupo Aeroportuario del Pacifico
PAC
$13.2B
$2.22M ﹤0.01%
8,974
+161
+2% +$42.3K
ING icon
1773
ING
ING
$94.8B
$2.21M ﹤0.01%
84,905
+2,504
+3% +$70.4K
UFCS icon
1774
United Fire Group
UFCS
$1.35B
$2.2M ﹤0.01%
59,491
+1,062
+2% +$39.2K
XMTR icon
1775
Xometry
XMTR
$4.56B
$2.2M ﹤0.01%
53,945
-181
-0.3% -$9.62K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.